Adicet Bio Inc (ACET) concluded trading on Wednesday at a closing price of $1.52, with 3.89 million shares of worth about $5.91 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.03% during that period and on May 01, 2024 the price saw a gain of about 2.01%. Currently the company’s common shares owned by public are about 82.17M shares, out of which, 67.18M shares are available for trading.
Stock saw a price change of -18.93% in past 5 days and over the past one month there was a price change of -35.59%. Year-to-date (YTD), ACET shares are showing a performance of -19.58% which decreased to -75.12% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.10 but also hit the highest price of $7.50 during that period. The average intraday trading volume for Adicet Bio Inc shares is 1.31 million. The stock is currently trading -25.84% below its 20-day simple moving average (SMA20), while that difference is down -31.28% for SMA50 and it goes to -23.95% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adicet Bio Inc (NASDAQ: ACET) currently have 82.17M outstanding shares and institutions hold larger chunk of about 43.14% of that.
The stock has a current market capitalization of $124.90M and its 3Y-monthly beta is at 1.94. It has posted earnings per share of -$3.32 in the same period. It has Quick Ratio of 8.41 while making debt-to-equity ratio of 0.12. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACET, volatility over the week remained 10.62% while standing at 7.43% over the month.
Analysts are in expectations that Adicet Bio Inc (ACET) stock would likely to be making an EPS of -$0.39 in the current quarter, while forecast for next quarter EPS is -$0.35 and it is -$1.88 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.51 which is -$0.27 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.72 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 43.84% while it is estimated to decrease by -0.99% in next year. EPS is likely to grow at an annualized rate of 29.10% for next 5-years, compared to annual growth of 19.75% made by the stock over the past 5-years.
On June 01, 2023, JP Morgan Downgrade their recommendations, while on September 21, 2022, JP Morgan Initiated their ratings for the stock with a price target of $23. Stock get an Outperform rating from SMBC Nikko on March 31, 2022.
